14 Tel Aviv biotech investors fund Israeli life sciences in 2026. aMoon, Pontifax, and OrbiMed lead the big rounds. Israeli life sciences raised $2.7B in 2025, a record year up 25%.
Israel turned its science base into a deep biotech scene. aMoon and Pontifax write the biggest cheques in the sector.
Israel Biotech Fund and OrbiMed back drug development at scale. Triventures and Peregrine fund the medtech founders.
Most biotech rounds need real science, clean IP, and a plan. Ellty tracks every data room open from aMoon and Pontifax reviewers.
This guide covers 14 active Tel Aviv biotech investors in 2026.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| aMoon | Healthtech / life-sciences VC | $1M-$100M+ | Biopharma, digital health, medtech | amoon.fund |
| Pontifax | Biotech / life-sciences VC | $5M-$30M+ | Biopharma, drug discovery, therapeutics | pontifax.com |
| Israel Biotech Fund | Biotech VC | $5M-$25M | Biotech, drug development, therapeutics | ibf.fund |
| OrbiMed Israel | Multi-stage life-sciences VC | $5M-$50M+ | Biopharma, medical devices, diagnostics | orbimed.com |
| Arkin Bio Ventures | Biotech / life-sciences VC | ~$10M | Oncology, immunology, rare diseases | arkin-capital.com |
| Triventures | Medtech / digital-health VC | $1M-$10M | Medtech, digital health, bio-convergence | triventures.vc |
| Peregrine Ventures | Medtech / healthcare VC | $1M-$20M | Medical devices, therapeutics, oncology | peregrinevc.com |
| Sanara Ventures | Medtech venture builder | $500K-$5M | Medtech, digital health, drug delivery | sanaracapital.com |
| Pitango HealthTech | Healthtech / life-sciences VC | $1M-$15M | Biopharma, medical devices, AI health | pitango.com |
| ALIVE Israel HealthTech Fund | Multi-stage healthtech VC | $5M-$20M+ | Healthtech, medtech, digital health | alivevc.com |
| Welltech Ventures | Healthtech VC | $500K-$5M | Healthtech, life sciences, femtech | welltechventures.com |
| Vertex Ventures Israel | Multi-sector VC | $1M-$15M | Healthtech, AI health, deep tech | vertexventures.co.il |
| Integra Holdings | Life-sciences venture builder | $500K-$5M | Life sciences, biotech, medical devices | integra-holdings.com |
| Maverick Ventures Israel | Multi-sector VC | $1M-$10M | Healthtech, life sciences, enterprise | maverickisrael.com |
Control your Tel Aviv biotech raise
Biotech VCs open your science and data room before your deck. Ellty logs every view.
Start free 14-day trialWhat a biotech VC funds
A biotech VC funds drug discovery, therapeutics, and devices. In Tel Aviv that means real science and strong patents.
Funds back deep research and a credible clinical path. A clean data room holds all your trial and IP files.
They check the science, the patents, and the regulatory route. Founders pitching biotech VCs in Dublin face the same bar.
Ellty gives each fund one trackable link and logs every open. You see who studied your trial data before the call.
Healthcare is Israel's next growth engine, with the potential to produce ten more mega-companies like Teva.
14 Tel Aviv biotech investors
1. aMoon
aMoon is Israel's largest healthtech and life-sciences fund, with $1.1B in assets.
Recent Activity: Made around 7 new investments in the year to Dec 2025, deploying around $300M into Israeli healthtech
LinkedIn: aMoon LinkedIn
Sector Focus: Biopharma, digital health, medtech, life sciences
Stage Focus: Seed to growth
Location: Tel Aviv, Israel
Website: amoon.fund
2. Pontifax
Pontifax is a biopharma specialist that crossed $1.34B in assets in 2025.
Recent Activity: Invested in Adcendo's Series C April 2026, exited CathWorks, made 6 investments in 2025
LinkedIn: Pontifax LinkedIn
Sector Focus: Biopharma, drug discovery, therapeutics
Stage Focus: Series A and B
Location: Tel Aviv, Israel
Website: pontifax.com
3. Israel Biotech Fund
Israel Biotech Fund backs drug development, from MediWound to Gamida Cell.
Recent Activity: Invested in drug-discovery firm Ukko Jan 2026, closed a $112M second fund
LinkedIn: Israel Biotech Fund LinkedIn
Sector Focus: Biotech, drug development, therapeutics
Stage Focus: Early to mid stage
Location: Tel Aviv, Israel
Website: ibf.fund
4. OrbiMed Israel
OrbiMed runs a dedicated Israel biotech fund from a $17B global platform.
Recent Activity: Raised a $307M second Israeli biotech fund, founded the FutuRx accelerator
LinkedIn: OrbiMed LinkedIn
Sector Focus: Biopharma, medical devices, diagnostics
Stage Focus: Series A to public
Location: Tel Aviv, Israel
Website: orbimed.com
5. Arkin Bio Ventures
Arkin Bio Ventures backs oncology and immunology drug founders in Israel.
Recent Activity: Closed a $100M Arkin Bio Ventures III Jan 2026, backed by Phoenix and Clal
LinkedIn: Arkin Holdings LinkedIn
Sector Focus: Oncology, immunology, inflammation, rare diseases
Stage Focus: Early stage
Location: Tel Aviv, Israel
Website: arkin-capital.com
6. Triventures
Triventures is a medtech and digital-health VC with over $100M in assets.
Recent Activity: Portfolio includes Cala and exited V-Wave, a bio-convergence and medtech focus
LinkedIn: Triventures LinkedIn
Sector Focus: Medtech, digital health, bio-convergence
Stage Focus: Seed to growth
Location: Tel Aviv, Israel
Website: triventures.vc
Share your science and track every VC open
Ellty shows when aMoon or OrbiMed opens your trial data and deck. Follow up fast.
Start free 14-day trial7. Peregrine Ventures
Peregrine Ventures is Israel's first healthcare fund and its most active in the sector.
Recent Activity: Invested in therapeutic-device firm Hairstetics March 2026, around $600M across five funds
LinkedIn: Peregrine Ventures LinkedIn
Sector Focus: Medical devices, therapeutics, digital health
Stage Focus: Pre-seed to advanced
Location: Tel Aviv, Israel
Website: peregrinevc.com
8. Sanara Ventures
Sanara Ventures is a Teva and Philips-backed medtech venture builder.
Recent Activity: Around 20 active portfolio companies, setting up a $100M follow-on fund
LinkedIn: Sanara Ventures LinkedIn
Sector Focus: Medtech, digital health, drug-delivery devices
Stage Focus: Seed, follow-on
Location: Tel Aviv, Israel
Website: sanaracapital.com
9. Pitango HealthTech
Pitango HealthTech backs biopharma and digital medicine from a $150M fund.
Recent Activity: Closed a $150M HealthTech fund Nov 2025, portfolio includes QuantHealth and TScan
LinkedIn: Pitango LinkedIn
Sector Focus: Biopharma, medical devices, digital medicine, AI health
Stage Focus: Seed, early stage
Location: Tel Aviv, Israel
Website: pitango.com
10. ALIVE Israel HealthTech Fund
ALIVE is a growth-stage healthtech fund with around $200M in assets.
Recent Activity: Held an initial close on its Growth fund in Q3 2025 for late-stage healthtech
LinkedIn: ALIVE LinkedIn
Sector Focus: Healthtech, medtech, digital health, life sciences
Stage Focus: Mid-to-late, growth
Location: Tel Aviv, Israel
Website: alivevc.com
11. Welltech Ventures
Welltech Ventures backs healthtech, life sciences, and femtech founders.
Recent Activity: Around 12 portfolio companies split across healthtech and life sciences
LinkedIn: Welltech Ventures LinkedIn
Sector Focus: Healthtech, life sciences, femtech, wellness
Stage Focus: Seed, Series A
Location: Tel Aviv, Israel
Website: welltechventures.com
12. Vertex Ventures Israel
Vertex Ventures Israel runs a healthtech practice alongside deeptech and AI.
Recent Activity: Backed C8 Health's $12M Series A July 2025 and Navina's $55M Series C
LinkedIn: Vertex Ventures Israel LinkedIn
Sector Focus: Healthtech, AI health, deep tech
Stage Focus: Seed to Series B
Location: Tel Aviv, Israel
Website: vertexventures.co.il
13. Integra Holdings
Integra Holdings commercializes Hebrew University life-sciences research.
Recent Activity: The exclusive gateway for Hebrew University spinouts, backed by Temasek and Arie Capital
LinkedIn: Integra Holdings LinkedIn
Sector Focus: Life sciences, biotech, medical devices, drug discovery
Stage Focus: Pre-seed, seed
Location: Jerusalem, Israel
Website: integra-holdings.com
14. Maverick Ventures Israel
Maverick Ventures Israel backs healthtech and life-sciences founders from Tel Aviv.
Recent Activity: Around 61 companies over 11 years across healthtech and enterprise tech
LinkedIn: Maverick Ventures Israel LinkedIn
Sector Focus: Healthtech, life sciences, enterprise tech
Stage Focus: Seed, early stage
Location: Tel Aviv, Israel
Website: maverickisrael.com
Drug discovery and trials
Drug discovery is the heart of Israeli biotech today. Pontifax and Israel Biotech Fund back it at every stage.
These programs run for years through trials and regulators. Funds reserve deep capital for each clinical milestone.
Founders share trial data, patents, and regulator letters under NDA. Secure file sharing beats emailing the files around.
Run a full IP due diligence review before you raise. Biotech funds probe your patent position very hard.
Medtech and digital health
Medtech and digital health pull steady Israeli capital. Triventures, Peregrine, and Sanara lead the field.
Devices need clinical proof, FDA clearance, and reimbursement. The path is long, but the exits here are often large.
A tight fundraising process matters even more in biotech. Ellty shows you exactly who studied each shared file.
Walk through the due diligence checklist for investors early. It maps closely to what aMoon and Peregrine ask in 2026.
Long timelines, big exits
Biotech takes a decade and deep capital to reach an exit. The payoffs can be enormous when a program finally works.
Israel produced Teva and a long wave of biotech exits. Patient funds here back founders for the entire long road.
Sensitive trial and patent data needs tight security controls. Ellty logs every open and lets you revoke access fast.
Send milestone updates to keep funds engaged for years. Trackable Ellty links show you who still reads them.
How to pitch a Tel Aviv biotech investor
Lead with the science, the IP, and a clinical plan.
- 1.Show strong science and defensible IP.Biotech VCs back a real patent moat.
- 2.Bring a credible clinical and regulatory plan.A clear path to trials de-risks the deal.
- 3.Show a strong scientific founding team.Pedigree and research matter most here.
- 4.Share one Ellty link per fund and track opens.Follow up when a partner reads your trial data.
How Ellty helps you land a biotech investor in Tel Aviv
You've found your Tel Aviv biotech VCs already. Set up a data room before your first pitch.
- 1.Upload your science, IP, and trial data to Ellty.Set NDA-gated access per biotech investor.
- 2.Share a unique trackable link with each fund.Each fund gets one link. Ellty logs every open.
- 3.Track opens and follow up the moment they read.Use Ellty analytics to time your follow-up.
Tel Aviv biotech investor questions
- Biotech and life-sciences VCs. aMoon, Pontifax, and OrbiMed lead the sector.
- Cheques run $1M-$50M+ in 2026. Drug programs need deep follow-on capital.
- Real science, strong IP, and a clinical plan. A patent moat matters most here.
- It produced Teva and deep science talent. Life sciences raised $2.7B in 2025.
- Often a decade to an exit. Funds back the long road with patient capital.
- Before outreach starts. Track who opens your science and IP docs.
